105 related articles for article (PubMed ID: 26589538)
1. Poor correlation between acute phase reactants and intestinal involvement in patients with onset of Crohn's disease under treatment with an interleukin-6 inhibitor due to seronegative arthropathy.
Zacarías Martínez L; Mateo Soria L; Mañosa Círia M; Clos Parals A; Cabré Gelada E; Domènech Morral E
Gastroenterol Hepatol; 2016 Dec; 39(10):670-672. PubMed ID: 26589538
[No Abstract] [Full Text] [Related]
2. [Adalimumab vasculitis in a patient with Crohn's disease].
Muñoz Villafranca C; Izu Belloso RM; Bravo Rodriguez MT; Basterra Olabarrieta S
Gastroenterol Hepatol; 2013 Apr; 36(4):296-7. PubMed ID: 23522950
[No Abstract] [Full Text] [Related]
3. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.
Molander P; Sipponen T; Kemppainen H; Jussila A; Blomster T; Koskela R; Nissinen M; Rautiainen H; Kuisma J; Kolho KL; Färkkilä M
J Crohns Colitis; 2013 Oct; 7(9):730-5. PubMed ID: 23182163
[TBL] [Abstract][Full Text] [Related]
4. [Medical management of pediatric Crohn's disease].
Zeng Y; Gong S
Zhonghua Er Ke Za Zhi; 2014 May; 52(5):345-8. PubMed ID: 24969931
[No Abstract] [Full Text] [Related]
5. [Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].
Sansó Sureda A; Rocamora Durán V; Sapiña Camaró A; Royo Escosa V; Bosque López MJ
Gastroenterol Hepatol; 2011 Oct; 34(8):546-50. PubMed ID: 21665330
[TBL] [Abstract][Full Text] [Related]
6. Bugs and drugs: Predicting response to therapy.
Ananthakrishnan AN
J Gastroenterol Hepatol; 2018 Sep; 33 Suppl 3():27. PubMed ID: 30187562
[No Abstract] [Full Text] [Related]
7. Accuracy of Rapid Fecal Calprotectin Test in Monitoring Inflammatory Bowel Diseases Under Treatment with TNFα Antagonists.
Tursi A; Elisei W; Picchio M; Giorgetti G; Brandimarte G
Dig Dis Sci; 2015 May; 60(5):1406-13. PubMed ID: 25445163
[TBL] [Abstract][Full Text] [Related]
8. A prospective 52 week mucosal healing assessment of small bowel Crohn's disease as detected by capsule endoscopy.
Hall B; Holleran G; Chin JL; Smith S; Ryan B; Mahmud N; McNamara D
J Crohns Colitis; 2014 Dec; 8(12):1601-9. PubMed ID: 25257546
[TBL] [Abstract][Full Text] [Related]
9. Autophagy genes variants and paediatric Crohn's disease phenotype: a single-centre experience.
Strisciuglio C; Auricchio R; Martinelli M; Staiano A; Giugliano FP; Andreozzi M; De Rosa M; Giannetti E; Gianfrani C; Izzo P; Troncone R; Miele E
Dig Liver Dis; 2014 Jun; 46(6):512-7. PubMed ID: 24656308
[TBL] [Abstract][Full Text] [Related]
10. When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel.
Pittet V; Froehlich F; Maillard MH; Mottet C; Gonvers JJ; Felley C; Vader JP; Burnand B; Michetti P; Schoepfer A;
J Crohns Colitis; 2013 Nov; 7(10):820-6. PubMed ID: 23664620
[TBL] [Abstract][Full Text] [Related]
11. Effect of intestinal resection on quality of life in Crohn's disease.
Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Sparrow MP; Florin TH; Gibson PR; Debinski H; Gearry RB; Macrae FA; Leong RW; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Desmond PV
J Crohns Colitis; 2015 Jun; 9(6):452-62. PubMed ID: 25855073
[TBL] [Abstract][Full Text] [Related]
12. Serial fecal calprotectin changes in children with Crohn's disease on treatment with exclusive enteral nutrition: associations with disease activity, treatment response, and prediction of a clinical relapse.
Gerasimidis K; Nikolaou CK; Edwards CA; McGrogan P
J Clin Gastroenterol; 2011 Mar; 45(3):234-9. PubMed ID: 20871409
[TBL] [Abstract][Full Text] [Related]
13. [Crohn's disease: Vulvar edema and swelling].
Abdou A; Zaouri H; El Moussaoui N; Senouci K; Hassam B; Ismaili N
Presse Med; 2016 Mar; 45(3):371-2. PubMed ID: 26830925
[No Abstract] [Full Text] [Related]
14. Diagnosis and Management of Crohn Disease.
Feld L; Glick LR; Cifu AS
JAMA; 2019 May; 321(18):1822-1823. PubMed ID: 30969326
[No Abstract] [Full Text] [Related]
15. Early change in faecal calprotectin predicts primary non-response to anti-TNFα therapy in Crohn's disease.
Pavlidis P; Gulati S; Dubois P; Chung-Faye G; Sherwood R; Bjarnason I; Hayee B
Scand J Gastroenterol; 2016 Dec; 51(12):1447-1452. PubMed ID: 27400728
[TBL] [Abstract][Full Text] [Related]
16. Bell's palsy in a patient receiving adalimumab for Crohn's disease.
Lu LX; Marshall JK
J Crohns Colitis; 2013 Apr; 7(3):e115. PubMed ID: 22868065
[No Abstract] [Full Text] [Related]
17. [Treatment of stenoses caused by Crohn's disease].
Esters P; Kienle P; Dignass A
Dtsch Med Wochenschr; 2013 Sep; 138(36):1785-9. PubMed ID: 24002880
[No Abstract] [Full Text] [Related]
18. EBV-associated plasmablastic lymphoma in a patient with Crohn's disease after adalimumab treatment.
Liu L; Charabaty A; Ozdemirli M
J Crohns Colitis; 2013 Apr; 7(3):e118-9. PubMed ID: 22902264
[No Abstract] [Full Text] [Related]
19. Hand-held fractional exhaled nitric oxide measurements as a non-invasive indicator of systemic inflammation in Crohn's disease.
Quenon L; Hindryckx P; De Vos M; De Looze D; Joos G; Brusselle G; Peeters H
J Crohns Colitis; 2013 Sep; 7(8):644-8. PubMed ID: 23083698
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus blepharitis in a patient with Crohn's colitis.
Kittai A; Ali MA; Borum M
Am J Med; 2014 Jun; 127(6):e1-2. PubMed ID: 24613714
[No Abstract] [Full Text] [Related]
[Next] [New Search]
